Results

Total Results: 1,147 records

Showing results for "event".

1. Evidence Summary: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
   August 22, 2023 - Although 2 trials (n = 654 [1 new] 30 ) compared event driven or intermittent vs daily PrEP, they were … with decreased risk of any adverse event vs daily oral PrEP (8% [10/119] vs 31% [37/119]; RR, 0.27 [ … There were also no differences between TAF/FTC vs TDF/FTC in rates of any kidney adverse event (10% vs … : 1.5% (40/2694) vs 1.9% (51/2693); RR, 0.78 (95% CI, 0.52-1.18)    Any adverse event: 94% (2523/2694 … PrEP (n = 535); 1 RCT of daily vs event-driven PrEP (n = 119) 1 New study of daily vs event-driven PrEP

2. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
   February 18, 2020 - Identification of dyslipidemia and calculation of 10-year CVD event risk requires universal lipids screening … use may be beneficial for the primary preven- tion of CVD events in some adults with a 10-year CVD event … diabetes, hypertension, or smok- ing); and (3) they have a calculated 10-year risk of a cardiovascular event … 75 years without a history of CVD who have 1 or more CVD risk factors and a calculated 10-year CVD event … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected

3. Figure. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Clinical Summary (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/yBxQssfCeRcD6BBeP2QjdQ
   November 07, 2016 - Population Adults aged 40–75 y with no history of CVD, ≥1 CVD risk factors, and calculated 10-y CVD event … ≥10% Adults aged 40–75 y with no history of CVD, ≥1 CVD risk factors, and calculated 10-y CVD event … patient will benefit from statin use depends on his or her absolute baseline risk of having a future CVD event … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected

4. Screening for Coronary Heart Disease With Electrocardiography: Clinical Summary of USPSTF Recommendation (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/awaTJS5m8ZC5vUTKHZfMwD
   July 23, 2012 - Calculators are available to ascertain a person's 10-year risk for a CHD event. … Several abnormalities on resting and exercise ECG are associated with an increased risk for a serious CHD event … However, the incremental information offered by screening asymptomatic adults at low risk for a CHD event

5. Archived: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication-november-2016
   November 13, 2016 - aged 40 to 75 years with no history of CVD, 1 or more CVD risk factors, and a calculated 10-year CVD event … diabetes, hypertension, or smoking); and 3) they have a calculated 10-year risk of a cardiovascular event … aged 40 to 75 years with no history of CVD, 1 or more CVD risk factors, and a calculated 10-year CVD event … diabetes, hypertension, or smoking); and 3) they have a calculated 10-year risk of a cardiovascular event … Thus, clinicians should discuss with patients the potential risk of having a CVD event and the expected

6. Modeling Study: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study/aspirin-to-prevent-cardiovascular-disease-preventive-medication
   April 26, 2022 - cohorts of men and women aged 40 to 79 years with up to 20% 10-year risk for an atherosclerotic CVD event … Exposures: Low-dose (≤100mg/d) aspirin for lifetime use, unless contraindicated by a bleeding event, … In both strategies, aspirin was stopped permanently after a major gastrointestinal bleeding event or … an intracranial hemorrhage event. … Additional event-level results are reported in eTables 5 and 6 in the JAMA Supplement.

7. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/6cRgd5whkAvSGESSQsrQLR
   January 01, 2020 - Several calculators and models are available to quantify a person’s 10-year CVD event risk. … Persons with a 10-year CVD event risk less than 7.5% are considered at low risk, and those with a 10- … Among US adults aged 50 to 59 years, 80% of women and 46% of men have an estimated 10-year CVD event … Risk factors can be combined in many ways to classify a person's risk for a CVD event. … In general, studies found that the ABI, hsCRP level, and CAC score tended to have positive event net

8. Zyao53-Sqrb6Ozzkzdmjjt (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
   December 01, 2003 - to adverse event: 6/124 37% 9% Adverse event rate: 83% 38% 18% 19% 19% Orlistat 120 mg: Dropout: 23 … event: 3/120 Adverse event rate: 87% Placebo: Dropout: 27/125 Due to adverse event: 3/125 Adverse event … Adverse event rate: 18/60 Placebo: Dropout: 10/59 Due to adverse event: NR Adverse event rate: 7/59 … : 55/181 Due to adverse event: 27/181 Placebo: Dropout: 50/188 Due to adverse event: 5/188 Data in … Dropout: NR Due to adverse event: 2/50 Metformin: Dropout: NR Due to adverse event: NR Table 3.

9. Archived: Evidence Summary: Obesity in Adults: Screening and Counseling, 2003 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
   December 15, 2003 - to adverse event: 13/395 Adverse event rate: 283/395 Placebo: Dropout: 55/201 Due to … event: 2/161 Adverse event rate: 18/161 Placebo: Dropout: 83/163 Due to adverse event 4/ … rate: 80% d GI Adverse event: 64% Placebo: Dropout: 16/147 (11%) Adverse event rate: … : 7/122 Adverse event rate: 79% Orlistat 60 mg: Dropout: 29/124 Due to adverse event: … 6/124 Adverse event rate: 83% Orlistat 120 mg: Dropout: 23/122 Due to adverse event:

10. Recommendation: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-screening-using-nontraditional-risk-assessment
    July 10, 2018 - Risk factors can be combined in many ways to classify a person's risk for a CVD event. … Several calculators and models are available to quantify a person’s 10-year CVD event risk. … Persons with a 10-year CVD event risk less than 7.5% are considered at low risk, and those with a 10- … Among US adults aged 50 to 59 years, 80% of women and 46% of men have an estimated 10-year CVD event … In general, studies found that the ABI, hsCRP level, and CAC score tended to have positive event net

11. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTJ_Zj3TAkhx45wWUDtNyt
    May 01, 2021 - CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event … with no history of CVD and who have 1 or more of these CVD risk factors and an estimated 10-year CVD event … risk factors (ie, dyslipid- emia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event … Age is one of the strongest risk factors for CVD, and the 10-year CVD event risk estimated by the ACC … The higher a person’s 10-year risk of a CVD event, the greater the chance of benefit from statin use.

12. Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RRALFxUMfP7TXazQY32ZbG
    June 12, 2018 - Total net reclassification improvements ranged from 3.6% (2.7% event; 0.6% nonevent) to 30% (17% event … Persons Without Event, No. Control Group Persons With Event, No. … It did not report event NRI and nonevent NRI. … Event NRI is calculated as the proportion of persons with an event who were appropriately reclassified … Overall, total NRIs range from 3.6% (2.7% event; 0.6% nonevent) to 30% (17% event; 19% nonevent) for

13. Evidence Summary: Cardiovascular Disease Risk: Screening With Electrocardiography | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/cardiovascular-disease-risk-screening-with-electrocardiography
    June 12, 2018 - Total net reclassification improvements ranged from 3.6% (2.7% event; 0.6% nonevent) to 30% (17% event … It did not report event NRI and nonevent NRI. … Event NRI is calculated as the proportion of persons with an event who were appropriately reclassified … Overall, total NRIs range from 3.6% (2.7% event; 0.6% nonevent) to 30% (17% event; 19% nonevent) for … NRIs; 0.6% nonevent NRIs) to 30% (17% event NRIs; 19% nonevent NRIs).

14. Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication
    August 23, 2022 - dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event … dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event … CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event … Age is one of the strongest risk factors for CVD, and the 10-year CVD event risk estimated by the ACC … The higher a person’s 10-year risk of a CVD event, the greater the chance of benefit from statin use.

15. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MLeu_yFpPwzcZwKG6fw5ZY
    April 26, 2022 - cohorts of men and women aged 40 to 79 years with up to 20% 10-year risk for an atherosclerotic CVD event … EXPOSURES Low-dose (�100 mg/d) aspirin for lifetime use, unless contraindicated by a bleeding event, … In both strategies, aspirin was stopped perma- nently after a major gastrointestinal bleeding event or … an intracra- nial hemorrhage event. … Additional event-level results are re- ported in eTables 5 and 6 in the Supplement.

16. Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication
    August 23, 2022 - CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event … CVD risk factors (ie, dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event … Age is one of the strongest risk factors for CVD, and the 10-year CVD event risk estimated by the ACC … The higher a person’s 10-year risk of a CVD event, the greater the chance of benefit from statin use. … Clinicians should discuss with patients the potential risk of having a CVD event and the expected benefits

17. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/SToafQ-B-qpCqz5_Jf43wK
    March 21, 2022 - dyslipidemia, diabetes, hypertension, or smoking, and have an estimated 10-year risk of a cardiovascular event … dyslipidemia, diabetes, hypertension, or smoking, and have an estimated 10-year risk of a cardiovascular event … High blood pressure. 10-year risk of a cardiovascular event … potential harms before deciding whether to offer a medicine. 10-year risk of a cardiovascular event

18. Recommendation: Cardiovascular Disease Risk: Screening With Electrocardiography | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-risk-screening-with-electrocardiography
    June 12, 2018 - Risk factors are combined in many ways to estimate a person's risk of a CVD event. … Persons with a 10-year CVD event risk greater than 20% are generally considered high risk, those with … a 10-year CVD event risk less than 10% are considered low risk, and those with a 10-year CVD event risk … Persons with a 10-year CVD event risk less than 7.5% are considered at low risk, and those with a 10- … year CVD event risk of 7.5% or greater are considered at elevated risk. 6 The USPSTF recommends that

19. Screening for Cardiovascular Disease Risk With Electrocardiography: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/meNqyNxrVyw_U4jdcrx3A2
    January 01, 2020 - FINDINGS For asymptomatic adults at low risk of CVD events (individuals with a 10-year CVD event risk … vides the opportunity for more intensive risk factor management to reduce the likelihood of such an event … areconsideredlowrisk,andthosewitha10-yearCVD event risk of 10% to 20% are considered intermediate risk … Per- sons with a 10-year CVD event risk less than 7.5% are considered at low risk, and those with a 10 … -year CVD event risk of 7.5% or greater are con- sidered at elevated risk.6 The USPSTF recommends that

20. U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Statin Use for the Primary Prevention of Cardiovascular Disease in Adults (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/statinscvdadultsdraftrsbulletin.pdf
    December 22, 2015 - blood pressure, or diabetes, or who smoke), and have at least a 7.5% risk of having a cardiovascular event … Statins are most beneficial for individuals who have a calculated 10- year risk of a cardiovascular event … People with between a 7.5% and 10% calculated 10-year risk of a cardiovascular event can also benefit